论文部分内容阅读
自1994年1月～1998年12月应用舒喘灵加息斯敏治疗咳嗽变异性哮喘30例,取得较为满意疗效,现报告如下。1 资料与方法1.1 临床资料全部病例均符合1993年全国儿科哮喘协作组所制订的咳嗽变异性哮喘诊断标准。共61例,年龄6个月～12个月13例,1岁～3岁22例,4岁～6岁16例,7岁～9岁10例;男41例,女20例。1.2 治疗方法按就诊顺序随机分成治疗组(30例)和对照组(31例)。治疗组口服舒喘灵0.1mg/kg·次,每日3次,息斯敏0.2mg/kg·次,每日1次,2周为1个疗程。对照组口服强
From January 1994 to December 1998 application of salbutamol plus aspirin treatment of cough variant asthma in 30 cases, and achieved more satisfactory results, are as follows. 1 Materials and Methods 1.1 Clinical data All cases are in line with the 1993 national pediatric asthma collaborative group developed cough variant asthma diagnostic criteria. A total of 61 cases, ranging in age from 6 months to 12 months in 13 cases, 1 to 3 years old in 22 cases, 4 years old to 6 years old in 16 cases, 7 years old to 9 years old in 10 cases; 41 males and 20 females. 1.2 treatment according to the order of treatment were randomly divided into treatment group (30 cases) and control group (31 cases). The treatment group oral salbutamol 0.1mg / kg · times, 3 times a day, astemizole 0.2mg / kg · times a day, 2 weeks for a course of treatment. Control group oral strong